As of 2025-03-25, the EV/EBITDA ratio of Homology Medicines Inc (FIXX) is 0.07. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. FIXX's latest enterprise value is -6.57 mil USD. FIXX's TTM EBITDA according to its financial statements is -92.11 mil USD. Dividing these 2 quantities gives us the above FIXX EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 7.0x - 12.6x | 9.8x |
| Forward P/E multiples | 13.6x - 16.9x | 15.2x |
| Fair Price | (911.26) - (842.08) | (836.90) |
| Upside | -3811.8% - -3530.1% | -3508.9% |
| Date | EV/EBITDA |